Logo image of TLT.AS

LONDON TUNNELS PLC/THE (TLT.AS) Stock Fundamental Analysis

AMS:TLT - Euronext Amsterdam - GB00BS28ZN53 - Common Stock - Currency: GBP

2.16  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TLT. TLT was compared to 60 industry peers in the Hotels, Restaurants & Leisure industry. While TLT seems to be doing ok healthwise, there are quite some concerns on its profitability. TLT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year TLT has reported negative net income.
TLT had a negative operating cash flow in the past year.
TLT.AS Yearly Net Income VS EBIT VS OCF VS FCFTLT.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -2M -4M -6M

1.2 Ratios

TLT has a worse Return On Assets (-28.11%) than 80.00% of its industry peers.
The Return On Equity of TLT (-47.36%) is worse than 65.00% of its industry peers.
Industry RankSector Rank
ROA -28.11%
ROE -47.36%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TLT.AS Yearly ROA, ROE, ROICTLT.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 200 400 600

1.3 Margins

TLT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TLT.AS Yearly Profit, Operating, Gross MarginsTLT.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

TLT has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, TLT has an improved debt to assets ratio.
TLT.AS Yearly Shares OutstandingTLT.AS Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M 40M 50M
TLT.AS Yearly Total Debt VS Total AssetsTLT.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

TLT has an Altman-Z score of 11.72. This indicates that TLT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of TLT (11.72) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that TLT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.05, TLT belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 11.72
ROIC/WACCN/A
WACCN/A
TLT.AS Yearly LT Debt VS Equity VS FCFTLT.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

TLT has a Current Ratio of 2.52. This indicates that TLT is financially healthy and has no problem in meeting its short term obligations.
TLT's Current ratio of 2.52 is amongst the best of the industry. TLT outperforms 98.33% of its industry peers.
A Quick Ratio of 2.52 indicates that TLT has no problem at all paying its short term obligations.
TLT has a better Quick ratio (2.52) than 98.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 2.52
TLT.AS Yearly Current Assets VS Current LiabilitesTLT.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

TLT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -99.34%.
EPS 1Y (TTM)-99.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-113.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

TLT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -36.72% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-84.2%
EPS Next 2Y-44.83%
EPS Next 3Y-36.72%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TLT.AS Yearly EPS VS EstimatesTLT.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TLT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TLT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLT.AS Price Earnings VS Forward Price EarningsTLT.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TLT.AS Per share dataTLT.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

TLT's earnings are expected to decrease with -36.72% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-44.83%
EPS Next 3Y-36.72%

More info and screens

0

5. Dividend

5.1 Amount

TLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LONDON TUNNELS PLC/THE

AMS:TLT (5/29/2025, 7:00:00 PM)

2.16

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.89%
Inst Owner ChangeN/A
Ins Owners71.74%
Ins Owner ChangeN/A
Market Cap151.74M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 14.75
P/tB 66.73
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS0.15
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.11%
ROE -47.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.52
Quick Ratio 2.52
Altman-Z 11.72
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-113.42%
EPS Next Y-84.2%
EPS Next 2Y-44.83%
EPS Next 3Y-36.72%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-91.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-275.13%
EBIT Next 3Y-59.95%
EBIT Next 5YN/A
FCF growth 1Y-2385.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1340.45%
OCF growth 3YN/A
OCF growth 5YN/A